Cart
sales@molnova.com
Spastazoline
CAS No. 2351882-11-4
Spastazoline( —— )
Catalog No. M21959 CAS No. 2351882-11-4
Spastazoline is a potent and selective inhibitor of spastin(Human spastin with IC50 of 99 nM ).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 71 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 107 | In Stock |
|
| 25MG | 216 | In Stock |
|
| 50MG | 317 | In Stock |
|
| 100MG | 455 | In Stock |
|
| 200MG | 631 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSpastazoline
-
NoteResearch use only, not for human use.
-
Brief DescriptionSpastazoline is a potent and selective inhibitor of spastin(Human spastin with IC50 of 99 nM ).
-
DescriptionSpastazoline is a potent and selective inhibitor of spastin(Human spastin with IC50 of 99 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorspastin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2351882-11-4
-
Formula Weight382.51
-
Molecular FormulaC20H30N8
-
Purity>98% (HPLC)
-
SolubilityDMSO:95 mg/ml(248.36 mM; Need ultrasonic)
-
SMILESCC(C)[C@@H]1CN(CCN1)c1nc(Nc2cc([nH]n2)C(C)(C)C)c2cc[nH]c2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cupido T, et al. Designing a chemical inhibitor for the AAA protein spastin using active site mutations. Nat Chem Biol. 2019 Feb 18.2. Pisa R , Cupido T , Steinman J B , et al. Analyzing Resistance to Design Selective Chemical Inhibitors for AAA Proteins[J]. Cell Chemical Biology, 2019, 26(9).
molnova catalog
related products
-
Caspase 1 Substrate ...
Caspase 1 Substrate 1 (ICE), chromogenic; Ac-YEVD-pNA
-
SV40 large T antigen...
SV40 large T antigen NLS is from Large T antigen residue 47 to 55, enables protein import into cell nucleus. This peptide is generated from Large T antigen residue 47 to 55.
-
Terrestrosin D
Terrestrosin D can induce apoptotic cell death and inhibit angiogenesis in xenograft tumor cells, cell cycle arrest and induction of apoptosis in cancer cells and endothelial cells might be plausible mechanisms of actions for the observed antitumor and antiangiogenic activities of terrestrosin D.
